Restructuring proposal adopted by creditors

3 years ago

Orphazyme A/S in restructuring Company announcement                                                                No. 28/2022                             …

Small Pharma To Present at the Jefferies Healthcare Conference in New York City on June 10, 2022

3 years ago

LONDON, May 30, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a…

Harvest One and Its Brands, LivRelief (TM) and Dream Water (TM), Report Continued Improvement in Adjusted EBITDA(1) Results for Fiscal Q3 2022

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2022) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or…

Croatia Insurance Launched Digital Citylights Equipped With AI-Based Software And Built-In Cameras Fighting The Dramatic Rise In Mental Health Issues

3 years ago

Anxiety Meter can test the anxiety levels of passers-by and refer the most stressed respondents to a free preventive check-up. …

Pharnext Announces On-Schedule Completion of Patient Enrollment in its Pivotal Phase III Trial of PXT3003, the PREMIER Trial, for the Treatment of Charcot-Marie-Tooth Disease Type 1A

3 years ago

PARIS, FRANCE / ACCESSWIRE / May 30 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-clinical stage…

Angle PLC Announces Partnership with Major United States Urology Group

3 years ago

PARTNERSHIP ESTABLISHED WITH A MAJOR UNITED STATES UROLOGY GROUP TO CONDUCT CLINICAL STUDIES IN PROSTATE CANCER AND AS A POTENTIAL…

Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand

3 years ago

CELLS PLATFORM INTEGRATES INNOVATIVE OFF-THE-SHELF IPSC CELL THERAPY DISCOVERY WITH DEVELOPMENT AND MANUFACTURINGHAMBURG, GERMANY / ACCESSWIRE / May 30, 2022…

The MUHC Foundation’s Le Bal Rouge raises $2 million for research into infection and immunity

3 years ago

MUHC Foundation’s Le Bal Rouge raises $2 M Le Bal Rouge 2022MONTREAL, May 28, 2022 (GLOBE NEWSWIRE) -- After two…

FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma

3 years ago

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with…

LifeLabs Opens its Newest Patient Service Centre in Brampton, Ontario

3 years ago

LifeLabs Builds on Commitment to Deliver Accessible Community Testing to Ontarians LifeLabs Opens its Newest Patient Service Centre in Brampton,…